Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionG-rich single-stranded DNA binding

POT1 IGHMBP2

7.46e-0521732GO:1990955
GeneOntologyCellularComponentactin-based cell projection

EPS8 MYO1D ESPNL ITGA6 CBR1 TIAM2 FAT1 PCDH15 PALLD EXOC4

1.17e-0427817410GO:0098858
GeneOntologyCellularComponentsite of polarized growth

EPS8 SETX USP9X CLASP2 TIAM2 IGHMBP2 TRPM1 PALLD EXOC4

2.79e-042531749GO:0030427
GeneOntologyCellularComponentcell cortex

EPS8 ARHGAP32 CTTNBP2 MYO1D CLASP2 TRIP10 SEPTIN6 ACTR1A MKLN1 ASTN2 EXOC4

2.90e-0437117411GO:0005938
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

ARHGAP32 HAUS6 VPS18 CTTNBP2 ALPK1 ATP8B2 SHANK3 SEPTIN6 KIAA2013 VPS13D NFIA TMCC2 LTN1 ASTN2 PALLD EXOC4

4.45e-094931741615368895
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

EPS8 SAMD1 SETX ERCC6 NSD2 HMGXB4 GON4L CLASP2 BCL7A NDUFA10 TRIM27 EXOSC2 KIAA2013 ACTR1A INTS6 GTF2F2 GZF1 NUP37 PRMT5 IGHMBP2 MTRFR LTN1 HLTF CRYBG1 DAAM1 YME1L1 ZNF574

7.93e-0914971742731527615
Pubmed

The in vivo Interaction Landscape of Histones H3.1 and H3.3.

SAMD1 SETX ERCC6 NSD2 POLA1 HMGXB4 POLA2 EXOSC2 ZEB2 GTF2F2 NFIA BRPF1 MKI67 HLTF ZNF649 AURKB

8.13e-086081741636089195
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

TRPM6 SRSF5 MYO1D DSG1 NSD2 POLA1 USP9X CLASP2 CLPX CMYA5 NDUFA10 CBR1 FANCD2 MRPL4 S100A9 ACTR1A PTPN11 NUP155 MOGS STRAP PRMT5 MKI67 PNPLA8 MGAM2

2.07e-0714251742430948266
Pubmed

Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis.

AKAP6 EPS8 USP9X PSME2 RYK SEPTIN6 S100A9 LMO7 PCDH15

6.70e-07195174917110338
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

SAMD9 ERCC6 MYO1D DSG1 ZC3H13 ITGA6 NDUFA10 TRIM27 EXOSC2 S100A9 ACTR1A GTF2F2 NUP155 MOGS STRAP LMO7 PRMT5 ANGEL2 MKI67 CRYBG1 AURKB

1.45e-0612571742136526897
Pubmed

Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.

ARHGAP32 MYO1D NSD2 DTNA USP9X ITGA6 CLASP2 CLPX FANCD2 NUDT12 PTPN11 NUP155 LTN1 MKI67 STYXL1 ROBO1 MPHOSPH9 YME1L1 AURKB

1.48e-0610491741927880917
Pubmed

Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.

ASNSD1 SAMD1 HAUS6 VPS18 SRSF5 POLA1 USP9X CLASP2 CLPX POLA2 FANCD2 INTS6 PRDM10 PTPN11 NOD1 MOGS STRAP PIK3CB SCG3 LSS ZNF574

3.38e-0613271742132694731
Pubmed

Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.

SAMD1 ZSWIM8 ERCC6 ATP7B NSD2 HMGXB4 BCL7A CLPX TRIM27 ENKD1 FANCD2 INTS6 FAT1 SAT1 BRPF1 LTN1 YME1L1 ZNF574 AURKB

3.63e-0611161741931753913
Pubmed

Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.

ZSWIM8 ARHGAP32 POLM CAMK2A USP9X ALPK1 GLB1L2 INTS6 FAT1 LMO7 STYXL1 CRYBG1 CPLANE1

4.69e-065521741310737800
Pubmed

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

ZSWIM8 HAUS6 SRSF5 USP9X CLASP2 ALPK1 NR4A1 POLA2 ENKD1 SEPTIN6 GTF2F2 STRAP NFIA DNAJA4 CRYBG1 LSS MPHOSPH9 AURKB

5.17e-0610381741826673895
Pubmed

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.

HAUS6 VPS18 ATP7B USP9X ITGA6 CLASP2 NDUFA10 CBR1 ATP8B2 FANCD2 GTF2F2 FAT1 PTPN11 STRAP LMO7 FURIN LTN1 LSS

6.96e-0610611741833845483
Pubmed

FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.

ERCC6 USP9X OBSCN CLASP2 SERPINA1 GTF2F2 VPS13D LMO7 IGHMBP2 C4A C4B HYDIN

8.58e-064971741236774506
Pubmed

A probability-based approach for high-throughput protein phosphorylation analysis and site localization.

DOCK1 HAUS6 SETX ERCC6 USP9X ZC3H13 POLA2 LMO7 MKI67 PALLD ZNF574 EXOC4

9.67e-065031741216964243
Pubmed

Mast cell protease 5 mediates ischemia-reperfusion injury of mouse skeletal muscle.

NDST2 C4A C4B

1.01e-059174315905575
Pubmed

Large-scale proteomics and phosphoproteomics of urinary exosomes.

EPS8 MYO1D ITGA1 PSME2 CBR1 TRIP10 TIAM2 S100A9 ACTR1A KCNG2 SERPINA1 VPS13D FAT1 MOGS CD14 KHK CFAP70

1.51e-0510161741719056867
Pubmed

Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions.

DOCK1 ARHGAP32 SRSF5 DSG1 DTNA CLPX TRIM27 TRIP10 TIAM2 MRPL4 S100A9 BRPF1 ROBO1 TNKS2 YME1L1 AURKB

1.62e-059161741632203420
Pubmed

A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.

HAUS6 MYO1D DSG1 POLA1 TRIM27 CBR1 EXOSC2 STRAP LMO7 BRPF1 MKI67 PALLD EXOC4 AURKB

1.86e-057241741436232890
Pubmed

HIV-1 Vpr degrades the HLTF DNA translocase in T cells and macrophages.

POLA1 LMO7 HLTF AURKB

1.95e-0532174427114546
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

HAUS6 NPR1 SRSF5 TSEN54 CLASP2 BCL7A CLPX ACTR1B ACTR1A SERPINA1 NUP155 STRAP DNAJA4 NUP37 PRMT5 MKI67 EXOC4 AURKB

2.16e-0511551741820360068
Pubmed

High-throughput analysis of the C4 polymorphism by a combination of MLPA and isotype-specific ELISA's.

C4A C4B

2.49e-052174219062096
Pubmed

Antigen-induced B cell apoptosis is independent of complement C4.

C4A C4B

2.49e-052174217645767
Pubmed

Anti-DNA autoreactivity in C4-deficient mice.

C4A C4B

2.49e-052174212207352
Pubmed

Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients.

C4A C4B

2.49e-052174227758680
Pubmed

FANCD2 promotes mitotic rescue from transcription-mediated replication stress in SETX-deficient cancer cells.

SETX FANCD2

2.49e-052174236543851
Pubmed

Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein.

C4A C4B

2.49e-05217423037333
Pubmed

The role of the 70 kDa subunit of human DNA polymerase alpha in DNA replication.

POLA1 POLA2

2.49e-05217428223465
Pubmed

Evidence of a role for C4 in modulating interstitial inflammation in experimental glomerulonephritis.

C4A C4B

2.49e-052174211726230
Pubmed

Quantitative variations in the expression of the mouse serum antigen Ss and its sex-limited allotype Slp.

C4A C4B

2.49e-05217424216347
Pubmed

Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain.

C4A C4B

2.49e-05217428428773
Pubmed

Complement C4 deficiency--a plausible risk factor for non-tuberculous mycobacteria (NTM) infection in apparently immunocompetent patients.

C4A C4B

2.49e-052174224638111
Pubmed

Neuronal L-Type Calcium Channel Signaling to the Nucleus Requires a Novel CaMKIIα-Shank3 Interaction.

CAMK2A SHANK3

2.49e-052174232019829
Pubmed

Transcriptional repression of C4 complement by hepatitis C virus proteins.

C4A C4B

2.49e-052174221345967
Pubmed

The complement component C4 of mammals.

C4A C4B

2.49e-05217422302180
Pubmed

Gene CNVs and protein levels of complement C4A and C4B as novel biomarkers for partial disease remissions in new-onset type 1 diabetes patients.

C4A C4B

2.49e-052174222151770
Pubmed

Comprehensive approach to study complement C4 in systemic lupus erythematosus: Gene polymorphisms, protein levels and functional activity.

C4A C4B

2.49e-052174229080553
Pubmed

C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production.

C4A C4B

2.49e-052174225339671
Pubmed

A study of association of the complement C4 mutations with systemic lupus erythematosus in the Malaysian population.

C4A C4B

2.49e-052174217728371
Pubmed

Structure and organization of the C4 genes.

C4A C4B

2.49e-05217426149580
Pubmed

Sequence heterogeneity of murine complementary DNA clones related to the C4 and C4-Slp isoforms of the fourth complement component.

C4A C4B

2.49e-05217426149581
Pubmed

Biochemistry and biology of anaphylatoxins.

C4A C4B

2.49e-05217423542363
Pubmed

C4 from C4-high and C4-low mouse strains have identical sequences in the region corresponding to the isotype-specific segment of human C4.

C4A C4B

2.49e-05217422387317
Pubmed

Structural studies on the murine fourth component of complement (C4). IV. Demonstration that C4 and Slp are encoded by separate loci.

C4A C4B

2.49e-05217427365238
Pubmed

Peritubular capillary C4d deposition in lupus nephritis different from antibody-mediated renal rejection.

C4A C4B

2.49e-052174217971360
Pubmed

Analysis of C4 and the C4 binding protein in the MRL/lpr mouse.

C4A C4B

2.49e-052174217971229
Pubmed

Plasma Complement 3 and Complement 4 Are Promising Biomarkers for Distinguishing NMOSD From MOGAD and Are Associated With the Blood-Brain-Barrier Disruption in NMOSD.

C4A C4B

2.49e-052174235898513
Pubmed

Borrelia burgdorferi outer surface protein C (OspC) binds complement component C4b and confers bloodstream survival.

C4A C4B

2.49e-052174228873507
Pubmed

Recombination of two homologous MHC class III genes of the mouse (C4 and Slp) that accounts for the loss of testosterone dependence of sex-limited protein expression.

C4A C4B

2.49e-05217423794341
Pubmed

Fine-tuned characterization of RCCX copy number variants and their relationship with extended MHC haplotypes.

C4A C4B

2.49e-052174222785613
Pubmed

Association between complement 4 copy number variation and systemic lupus erythematosus: a meta-analysis.

C4A C4B

2.49e-052174232691186
Pubmed

The androgen-dependent C4-Slp gene is driven by a constitutively competent promoter.

C4A C4B

2.49e-05217428390682
Pubmed

Structure and expression of murine fourth complement component (C4) and sex-limited protein (Slp).

C4A C4B

2.49e-05217423902619
Pubmed

Structural polymorphism of murine C4 and its linkage to H-2.

C4A C4B

2.49e-05217427373044
Pubmed

Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups.

C4A C4B

2.49e-05217421357031
Pubmed

Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s.

C4A C4B

2.49e-052174216098595
Pubmed

Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura.

C4A C4B

2.49e-052174215787745
Pubmed

Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study.

C4A C4B

2.49e-052174230026462
Pubmed

A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B.

C4A C4B

2.49e-05217426559257
Pubmed

Polymerase chain reaction based C4AQ0 and C4BQ0 genotyping: association with systemic lupus erythematosus in southwest Han Chinese.

C4A C4B

2.49e-052174212480675
Pubmed

Low C4, C4A and C4B gene copy numbers are stronger risk factors for juvenile-onset than for adult-onset systemic lupus erythematosus.

C4A C4B

2.49e-052174226800705
Pubmed

Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein.

C4A C4B

2.49e-05217421699796
Pubmed

Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp.

C4A C4B

2.49e-05217422997024
Pubmed

Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences.

C4A C4B

2.49e-05217423624865
Pubmed

Insights on the relationship between complement component C4 serum concentrations and C4 gene copy numbers in a Western Australian systemic lupus erythematosus cohort.

C4A C4B

2.49e-052174230041577
Pubmed

Complete cDNA sequence of the fourth component of murine complement.

C4A C4B

2.49e-05217423862104
Pubmed

Alpha1-antitrypsin inhibits the activity of the matriptase catalytic domain in vitro.

ST14 SERPINA1

2.49e-052174218723439
Pubmed

Schizophrenia risk from complex variation of complement component 4.

C4A C4B

2.49e-052174226814963
Pubmed

Both α-1-antitrypsin Z phenotypes and low caeruloplasmin levels are over-represented in alcohol and nonalcoholic fatty liver disease cirrhotic patients undergoing liver transplant in Ireland.

ATP7B SERPINA1

2.49e-052174229324588
Pubmed

Identifying and treating ROBO1-ve /DOCK1+ve prostate cancer: An aggressive cancer subtype prevalent in African American patients.

DOCK1 ROBO1

2.49e-052174232687658
Pubmed

The intrinsically disordered N-terminal region of mouse DNA polymerase alpha mediates its interaction with POT1a/b at telomeres.

POLA1 POT1

2.49e-052174233711210
Pubmed

Promoter elements of the mouse complement C4 gene critical for transcription activation and start site location.

C4A C4B

2.49e-05217428132550
Pubmed

Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A.

C4A C4B

2.49e-05217422395880
Pubmed

Effects of Complement C4 Gene Copy Number Variations, Size Dichotomy, and C4A Deficiency on Genetic Risk and Clinical Presentation of Systemic Lupus Erythematosus in East Asian Populations.

C4A C4B

2.49e-052174226814708
Pubmed

Slp is an essential component of an EDTA-resistant activation pathway of mouse complement.

C4A C4B

2.49e-05217421438267
Pubmed

Genetic deficiency of complement isoforms C4A or C4B predicts improved survival of metastatic renal cell carcinoma.

C4A C4B

2.49e-052174219150565
Pubmed

Elevated levels of endogenous apoptotic DNA and IFN-alpha in complement C4-deficient mice: implications for induction of systemic lupus erythematosus.

C4A C4B

2.49e-052174217506029
Pubmed

Low C4 gene copy numbers are associated with superior graft survival in patients transplanted with a deceased donor kidney.

C4A C4B

2.49e-052174223715124
Pubmed

Complete nucleotide and derived amino acid sequences of the fourth component of mouse complement (C4). Evolutionary aspects.

C4A C4B

2.49e-05217422993295
Pubmed

Activation of SSAT1/ALOX15 Axis Aggravates Cerebral Ischemia/Reperfusion Injury via Triggering Neuronal Ferroptosis.

SAT1 ALOX15

2.49e-052174235090880
Pubmed

Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice.

C4A C4B

2.49e-052174233353966
Pubmed

Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes.

C4A C4B

2.49e-05217422900855
Pubmed

Genetic deficiency in complement component 4b does not alter radiation-induced lung disease in mice.

C4A C4B

2.49e-052174223259761
Pubmed

Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction.

C4A C4B

2.49e-052174222737222
Pubmed

Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection.

C4A C4B

2.49e-052174216565498
Pubmed

Complete deficiencies of complement C4A and C4B including 2-bp insertion in codon 1213 are genetic risk factors of systemic lupus erythematosus in Thai populations.

C4A C4B

2.49e-052174215998580
Pubmed

Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice.

C4A C4B

2.49e-052174219933335
Pubmed

Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4.

C4A C4B

2.49e-05217422459207
Pubmed

Common variation at 2q22.3 (ZEB2) influences the risk of renal cancer.

ZEB2 PDZD2

2.49e-052174223184150
Pubmed

Genetically determined partial complement C4 deficiency states are not independent risk factors for SLE in UK and Spanish populations.

C4A C4B

2.49e-052174222387014
Pubmed

Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner.

C4A C4B

2.49e-052174223749435
Pubmed

Copy number variations of complement component C4 are associated with Behçet's disease but not with ankylosing spondylitis associated with acute anterior uveitis.

C4A C4B

2.49e-052174223918728
Pubmed

Sequence determination of the thiolester site of the fourth component of human complement.

C4A C4B

2.49e-05217426950384
Pubmed

Visual demonstration of the organization of the human complement C4 and 21-hydroxylase genes by high-resolution fluorescence in situ hybridization.

C4A C4B

2.49e-05217428660986
Pubmed

Beta-centractin: characterization and distribution of a new member of the centractin family of actin-related proteins.

ACTR1B ACTR1A

2.49e-05217427696711
Pubmed

Restriction fragment analysis of H-2 recombinant mouse strains with crossovers between E alpha and C4 genes.

C4A C4B

2.49e-05217422572548
Pubmed

Regulation of eukaryotic DNA replication at the initiation step.

POLA1 POLA2

2.49e-052174212546699
Pubmed

C4d-positive chronic rejection: a frequent entity with a poor outcome.

C4A C4B

2.49e-052174218091514
Pubmed

Genes for murine fourth complement component (C4) and sex-limited protein (Slp) identified by hybridization to C4- and Slp-specific cDNA.

C4A C4B

2.49e-05217426589636
Pubmed

The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues.

C4A C4B

2.49e-052174212115608
Pubmed

Trappin-2 promotes early clearance of Pseudomonas aeruginosa through CD14-dependent macrophage activation and neutrophil recruitment.

SERPINA1 CD14

2.49e-052174219264904
Cytoband11q25

GLB1L3 GLB1L2 PRDM10

1.33e-0426175311q25
Cytoband7q31

CTTNBP2 PNPLA8 EXOC4

1.49e-042717537q31
GeneFamilyBeta-gamma crystallin domain containing

CRYBG2 CRYBG1

1.53e-04313021360
GeneFamilyCadherin related

CLSTN3 FAT1 PCDH15

2.29e-0417130324
GeneFamilyDNA polymerases

POLM POLA1 POLA2

5.79e-04231303535
CoexpressionHE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL

HAUS6 ASRGL1 CES1 NSD2 POLA1 HMGXB4 TSEN54 BCL7A POLA2 EXOSC2 ENOPH1 ST14 FANCD2 ACTR1B GTF2F2 NUP155 NUP37 PRMT5 BRPF1 MTRFR HPF1 MKI67 HLTF CRYBG1 MPHOSPH9 ZNF574 AURKB

8.16e-07142317427M45722
CoexpressionHE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL

SAMD1 HAUS6 ASRGL1 NSD2 POLA1 POT1 HMGXB4 ITGA6 PHF7 BCL7A POLA2 FANCD2 MAST4 NUP155 NUP37 MTRFR MKI67 HLTF MTHFD2L MPHOSPH9 AURKB

1.22e-0693917421M45768
CoexpressionNAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN

AKAP6 ZSWIM8 CRYBG2 SAMD9 NSD2 DTNA ZBTB43 OBSCN ITGA6 EXOSC2 RYK MAST4 SIGLEC7 PIK3CB BRPF1 MKI67 C4A C4B ALDH4A1 KHK

2.86e-0690917420M41018
CoexpressionLAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS

EPS8 MYO1D ITGA1 NR4A1 CBLB ZEB2 LMO7 ROBO1 PALLD

2.99e-061771749M39245
CoexpressionGSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP

POLA1 BCL7A ZEB2 SEPTIN6 VPS13D MOGS NFIA ANGEL2 HLTF

7.77e-061991749M8396
CoexpressionCAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_DN

CBR1 SERPINA1 MGAM2

1.57e-0581743M41071
CoexpressionLAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP

HAUS6 NSD2 POLA1 POLA2 EXOSC2 ST14 FANCD2 FAT1 NUP155 HPF1 MKI67 AURKB

1.69e-0540217412MM454
CoexpressionHE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL

SAMD1 HAUS6 ASRGL1 NSD2 POLA1 HMGXB4 POLA2 FANCD2 NUP37 MTRFR HPF1 MKI67 HLTF MPHOSPH9 ZNF574 AURKB

1.69e-0569417416M45767
CoexpressionLAKE_ADULT_KIDNEY_C28_INTERSTITIUM

EPS8 ITGA1 CBLB ZEB2 NFIA PALLD

2.38e-05861746M39247
CoexpressionGAL_LEUKEMIC_STEM_CELL_DN

LILRA2 POLM NR4A1 POLA2 S100A9 SERPINA1 MOGS CD14 ALDH4A1

3.11e-052371749M4502
CoexpressionHAMAI_APOPTOSIS_VIA_TRAIL_UP

HAUS6 ASRGL1 SETX CTTNBP2 USP9X ITGA6 NUDT12 GTF2F2 DNAJA4 MKI67 HLTF TRPM1 DAAM1 CPLANE1 PALLD

3.44e-0565617415M18979
CoexpressionHE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL

ASNSD1 SAMD1 HAUS6 ASRGL1 NSD2 POLA1 HMGXB4 TSEN54 POLA2 CBR1 EXOSC2 ENOPH1 FANCD2 PTPN11 NUP155 NUP37 PRMT5 MTRFR HPF1 MKI67 HLTF MPHOSPH9 AURKB

3.74e-05136317423M45782
CoexpressionBUSSLINGER_GASTRIC_G_CELLS

CES1 DTNA MAST4 SCG3 TM4SF4 FEV

4.99e-05981746M40018
CoexpressionGSE6259_DEC205_POS_DC_VS_CD4_TCELL_UP

MICAL1 CLPX UBXN2B LTN1 LPIN2 MKLN1 LSS DAAM1

5.79e-051991748M6773
CoexpressionDACOSTA_UV_RESPONSE_VIA_ERCC3_DN

DOCK1 EPS8 SETX USP9X HMGXB4 ITGA6 CLASP2 CBLB ZEB2 RYK GTF2F2 FAT1 LTN1 MKLN1 HLTF MPHOSPH9 DAAM1

5.98e-0585617417M4500
CoexpressionGSE27786_LSK_VS_CD4_TCELL_DN

SETX ZC3H13 STING1 CBR1 VPS13D DNAJA4 HLTF DAAM1

6.00e-052001748M4747
CoexpressionGSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP

ARHGAP32 ASRGL1 POLA2 ACTR1A FAT1 NUP155 STRAP MKLN1

6.00e-052001748M3461
CoexpressionGSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP

ASNSD1 CRYBG2 EXOSC2 ENKD1 RYK GTF2F2 HPF1 MKI67

6.00e-052001748M9767
CoexpressionGSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP

MICAL1 SETX STING1 ST14 NOD1 SIGLEC7 SAT1 HPF1

6.00e-052001748M7147
CoexpressionGSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP

NDST2 PHF7 CLASP2 ATP8B2 NFIA LPIN2 KHK EXOC4

6.00e-052001748M6606
CoexpressionBUSSLINGER_DUODENAL_MATURE_ENTEROCYTES

MICAL1 ZSWIM8 CRYBG2 TRIP10 ATP8B2 SERPINA1 LMO7 LPIN2 TM4SF4

6.19e-052591749M40029
CoexpressionLAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES

AKAP6 EPS8 MYO1D ITGA1 NR4A1 CBLB PALLD

8.21e-051551747M39246
CoexpressionYAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15

MKI67 ROBO1 ALOX15 AURKB

9.36e-05361744MM1284
CoexpressionYAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15

MKI67 ROBO1 ALOX15 AURKB

9.36e-05361744M2687
CoexpressionDEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN

ATP7B ITGA6 GLB1L2 POLA2 TRIM27 CBR1 MKI67 C4B KHK

1.01e-042761749M3063
CoexpressionLASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN

ZSWIM8 ARHGAP32 ASRGL1 GLB1L3 NSD2 NDST2 CLASP2 GLB1L2 KIAA2013 FANCD2 ACTR1A VPS13D PRDM10 NFIA MKI67 TNKS2

1.01e-0480717416M14594
CoexpressionPUJANA_BRCA2_PCC_NETWORK

NSD2 POLA1 HMGXB4 EXOSC2 SEPTIN6 CD1A FAT1 MKI67 HLTF MPHOSPH9 AURKB

1.38e-0442617411M9516
CoexpressionZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP

MICAL1 LILRA2 SAMD9 CES1 STING1 PSME2 ALPK1 CBR1 ZEB2 ST14 S100A9 SERPINA1 NOD1 SIGLEC7 SAT1 CD14 STYXL1 TET3

1.45e-04101217418M40868
CoexpressionDODD_NASOPHARYNGEAL_CARCINOMA_UP

HAUS6 NSD2 POLA1 POT1 HMGXB4 ITGA1 ENOPH1 SHANK3 B4GALT6 GTF2F2 UBXN2B NUP155 CD14 STRAP NUP37 MTRFR ANGEL2 MKI67 MKLN1 MTHFD2L ROBO1 MPHOSPH9

1.68e-04140717422M14427
CoexpressionROSS_LEUKEMIA_WITH_MLL_FUSIONS

MICAL1 CES1 CLASP2 ZEB2 PALLD

1.84e-04791745M12695
CoexpressionGSE40493_BCL6_KO_VS_WT_TREG_UP

USP9X VPS13D PTPN11 LPIN2 PNPLA8 TNKS2 YME1L1

1.87e-041771747M9401
CoexpressionSILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN

POT1 CLASP2 STYXL1

2.18e-04181743M16533
CoexpressionDOANE_RESPONSE_TO_ANDROGEN_DN

EPS8 NSD2 BCL7A MAST4 LPIN2 KHK PAX9 PALLD

2.23e-042421748M12816
CoexpressionLEE_AGING_NEOCORTEX_UP

NR4A1 SAT1 DNAJA4 C4A C4B

2.33e-04831745MM1022
CoexpressionAtlasDevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#5_top-relative-expression-ranked_1000

DOCK1 SETX POT1 CLASP2 ZEB2 HLTF TNKS2

5.22e-06841717gudmap_developingKidney_e15.5_Endothelial cells_1000_k5
CoexpressionAtlasDevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000

DOCK1 SETX USP9X POT1 CLASP2 NUP155 MKLN1 TNKS2

2.46e-051461718gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5
CoexpressionAtlasMyeloid Cells, DC.103-11b+.Lv, CD45+ CD11c+ MHC-II + CD11b high CD103-, Liver, avg-3

DOCK1 EPS8 NPR1 ITGA1 ALPK1 NR4A1 ZEB2 B4GALT6 S100A9 SERPINA1 SIGLEC7 SAT1 CD14

3.01e-0541117113GSM538239_500
CoexpressionAtlasDevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000

DOCK1 TNK1 ARHGAP32 ASRGL1 MYO1D USP9X POT1 GLB1L2 CBLB ST14 B4GALT6 NUP155 MKLN1 HLTF SCUBE3 CRYBG1 TNKS2 CPLANE1

5.54e-0577417118gudmap_developingKidney_e15.5_cortic collect duct_1000
CoexpressionAtlasMyeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3

DOCK1 EPS8 ITGA6 ALPK1 ZEB2 RYK B4GALT6 CD14 NFIA C4A C4B KHK ALOX15

5.77e-0543817113GSM605850_500
CoexpressionAtlasDevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000

DOCK1 HAUS6 ASRGL1 SETX NSD2 DTNA USP9X POT1 CLASP2 POLA2 RYK NUP155 LPIN2 MKLN1 HLTF SCUBE3 MPHOSPH9 TNKS2

6.01e-0577917118gudmap_developingKidney_e15.5_Cap mesenchyme_1000
CoexpressionAtlasDevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_top-relative-expression-ranked_1000

DOCK1 TNK1 ASRGL1 SETX NSD2 USP9X POT1 HMGXB4 GLB1L2 ST14 B4GALT6 PTPN11 BRPF1 HLTF SCUBE3 CRYBG1 TNKS2 CPLANE1

8.56e-0580117118gudmap_developingKidney_e15.5_ureter tip_1000_flank cortic collct
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#5_top-relative-expression-ranked_1000

DOCK1 ASRGL1 SETX USP9X CLASP2 GLB1L2 ZEB2 PTPN11 NFIA MKLN1 TNKS2 CPLANE1

9.42e-0539717112gudmap_developingLowerUrinaryTract_e14.5_ bladder_1000_k5
CoexpressionAtlasDevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#1_top-relative-expression-ranked_500

DOCK1 SETX USP9X GLB1L2 ZEB2 NFIA MKLN1 TNKS2 CPLANE1

1.11e-042311719gudmap_developingLowerUrinaryTract_e14.5_ bladder_500_k1
ToppCell5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ARHGAP32 MYO1D CES1 CBR1 LMO7 CRYBG1 CPLANE1 PALLD HYDIN ALOX15

6.29e-09197175105c4cee914baf7cb43e9cb99cc9e3ae823856dc15
ToppCellRA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 ASTN2 PALLD PDZD2

7.95e-081941759c3535f7cc0076653c72db582047cff053c322397
ToppCellCOVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 DNAJA4 PALLD

6.41e-071821758287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCellLV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 PALLD PDZD2

6.97e-071841758ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCellLV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 PALLD PDZD2

7.26e-0718517586baccb26f999145e51b91d94315bf8d4655bef31
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

SETX ZC3H13 ITGA1 VPS13D PRDM10 TGFBRAP1 LTN1 TET3

7.56e-07186175803db813598b67b1e08f759758a1c2023396921fa
ToppCellRV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 PALLD PDZD2

8.53e-0718917585e80c47f63980904c4c1ff02c201b67b456a0974
ToppCellLV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 PALLD PDZD2

8.87e-071901758de5ef606a002f85c2e0e3a36c1f259d0b85a76ff
ToppCellRV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 PALLD PDZD2

8.87e-071901758fe8e78922c8ae928ef9a80bffd67868d5a87a091
ToppCellLV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 PALLD PDZD2

9.23e-07191175825f3eb34f4e70761e81e84c8a5829f216108cbc6
ToppCellNS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

AKAP6 CES1 NFIA CFAP70 CPLANE1 DNAH9 HYDIN ALOX15

9.98e-071931758ea345d34440b25f65358a53dc72831998d1c3620
ToppCellRA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 ASTN2 PALLD

1.04e-06194175889812fb164065041357bb37a3c2d87028ec3de4e
ToppCellsevere-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ZEB2 S100A9 SERPINA1 SAT1 CD14 TM4SF4 IL17RA TET3

1.21e-061981758a77f3440d7fb6a50066abc7e9ad59e83798ef13d
ToppCellsevere-HLA-DR-_S100A+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

LILRA2 CES1 ZBTB43 ZEB2 S100A9 SERPINA1 CD14 IL17RA

1.30e-062001758a5eb50cbf3e94f0b3aa0fbef888989a11cffea37
ToppCellcontrol|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ARHGAP32 MYO1D CES1 ST14 LMO7 CPLANE1 PALLD ALOX15

1.30e-06200175897f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCellNS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ARHGAP32 MYO1D CES1 ST14 LMO7 CPLANE1 PALLD ALOX15

1.30e-062001758ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell10x5'-bone_marrow-Myeloid_Monocytic-Cycling_mono|bone_marrow / Manually curated celltypes from each tissue

CES1 ZBTB43 S100A9 SERPINA1 CD14 MKI67 ALDH4A1

2.01e-061481757de35eeefad0e27a0d127e2e4bedead2bddb75152
ToppCell5'-Adult-Appendix-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LILRA2 CES1 ZEB2 S100A9 KCNG2 SERPINA1 CD14

5.04e-0617017571c3c03821c90d41de92fef3278f71093a7fd709c
ToppCell10x5'-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue

ASRGL1 CES1 S100A9 SERPINA1 CD14 MKI67 AURKB

5.65e-061731757783b8fa08b9d8f597f251793eae164151662f1f9
ToppCellPND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

MICAL1 NSD2 POLA1 SEPTIN6 HPF1 MKI67 HLTF

5.87e-06174175709b091e24317c3f7bac043f04762a533e30793de
ToppCell3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CES1 CASR NR4A1 SCG3 TM4SF4 FEV TPH1

5.87e-061741757a62531ebf16b32b249168dca11b870f63a8aa81c
ToppCell5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CES1 KCNH6 SCG3 TM4SF4 CRYBG1 FEV TPH1

6.32e-06176175771f96cace3f20fbef975037f4deff9b82b0282a1
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TNMD DAW1 STYXL1 CFAP70 DNAH9 HYDIN LRRC36

6.56e-061771757ae01c19403a09f7ba5e4beafdfcd1b8eebdadcb7
ToppCellPBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)

TNK1 NR4A1 KCNH6 DNAJA4 MTRFR HLTF ZNF649

6.56e-0617717573d1b142aa2bd18df14816abaca356596b297394e
ToppCellfacs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TNMD DAW1 STYXL1 CFAP70 DNAH9 HYDIN LRRC36

6.56e-061771757bd3d07bdef6e903995d4bbfb6ff3a5e1d9fb70cc
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

SCG3 TMCC2 TM4SF4 ASTN2 FEV DNAH9 TPH1

6.81e-06178175730ca37f70d267cc9b40ca3e211f16d30360c3e6b
ToppCell3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

ARHGAP32 ATP7B NSD2 NR4A1 CMYA5 LMO7 DNAJA4

7.06e-0617917576e965e424eebef50f0202cff75f458be395cfca1
ToppCellPBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ASRGL1 NSD2 S100A9 SERPINA1 CD14 MKI67 IL17RA

7.06e-061791757e1bfd553c043ebc070ccf8545d489ba16d9b2ef4
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NPR1 CTTNBP2 DTNA ITGA1 FAT1 ROBO1 PALLD

7.59e-0618117575f2d3a08577c440c944778d07aa993c6e7873f3d
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

NPR1 CTTNBP2 DTNA ITGA1 FAT1 ROBO1 PALLD

7.59e-061811757c7c5f7d4c397b4613c772413a0a679377efffff3
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LILRA2 ZEB2 S100A9 SERPINA1 SAT1 CD14 DNAJA4

8.45e-061841757d7f348aa8901d819c68da20728b9238407bcdca9
ToppCellCOVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type

EPS8 SERPINA1 FAT1 MAST4 NFIA ASTN2 HYDIN

8.45e-06184175751ed1ebfdef45149541917c66cbacad87072e51f
ToppCell3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CES1 KCNH6 SCG3 TM4SF4 CRYBG1 FEV TPH1

8.76e-061851757eb78614c4acf8d2ce7874d7e51e16997b76127ef
ToppCell3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Cycling_pre-Myeloid-2|lymph-node_spleen / Manually curated celltypes from each tissue

LILRA2 CES1 ALPK1 S100A9 UBXN2B MKI67 TET3

9.39e-0618717573c10b8501226c69d71bcd99dc1c064a3c2154f87
ToppCellCOVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type

AKAP6 DTNA OBSCN CMYA5 NFIA PALLD PDZD2

1.04e-051901757918ad5037881212008f9f69d5df5da91fd01422c
ToppCellLA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 PALLD

1.08e-0519117575d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

IL11 EPS8 ITGA1 NR4A1 CBLB ZEB2 PALLD

1.08e-0519117571caf726bd07fdca389e678fc16304a6ef1790423
ToppCellrenal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

IL11 EPS8 ITGA1 NR4A1 CBLB ZEB2 PALLD

1.08e-0519117573d60c46bced2984c27a1fcf2910bc38b31fb0148
ToppCellSmart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

CES1 GLB1L2 FANCD2 MAST4 NFIA HYDIN AURKB

1.12e-051921757d6f656be2698bd215717d35f4e7ab727c08c61e0
ToppCellLV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 PALLD

1.12e-051921757ad19e2c1d36a0566c9b12ced10db78f4781c8ea6
ToppCell3'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CES1 KCNH6 SERPINA1 SCG3 TM4SF4 FEV TPH1

1.12e-0519217570b506fb5bca54a50949932293c6f86d974a3acdd
ToppCell5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

LILRA2 ZEB2 S100A9 SERPINA1 SIGLEC7 SAT1 CD14

1.12e-05192175762eac1b8aed4fb924946b58c0237313f697a0136
ToppCellURO|World / Disease, Lineage and Cell Type

LILRA2 CES1 ZEB2 S100A9 SERPINA1 CD14 IL17RA

1.15e-051931757421dc0996c6c973f88e90197b651255ae4dd13a2
ToppCellhuman_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

NSD2 POLA1 POLA2 FANCD2 MKI67 MPHOSPH9 AURKB

1.15e-0519317574b9fa2a4424f8abe63fa7bee78db93dda04ab15f
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

NDST2 ZEB2 S100A9 SERPINA1 CD14 DAW1 FURIN

1.15e-051931757d9bb77214bb92e8392cf74e3bfdf177a96fd71ea
ToppCellCOVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 PALLD

1.15e-051931757dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell368C-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

CES1 POLA1 TGFBRAP1 MKI67 CPLANE1 PALLD AURKB

1.15e-0519317575f5904cec8b2967154ef2eab3c48f51df53aca4a
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA1 ZEB2 LPIN2 ROBO1 PDE5A DAAM1 PALLD

1.19e-05194175790efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA1 ZEB2 LPIN2 ROBO1 PDE5A DAAM1 PALLD

1.19e-051941757df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCellIPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class

MYO1D MAST4 NFIA LMO7 CFAP70 DNAH9 HYDIN

1.23e-051951757fce0c29574bb7aab181b9c00feb42681e285d1f2
ToppCellCOVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type

AKAP6 DTNA OBSCN CMYA5 MAST4 LMO7 PALLD

1.23e-05195175775fc81bddb246dca3b437fb60827b1d4fe416405
ToppCellIPF-Multiplet|IPF / Disease state, Lineage and Cell class

MYO1D MAST4 NFIA LMO7 CFAP70 DNAH9 HYDIN

1.23e-051951757eacc0449ae6f3ad8002268cd061467684c6fb9a7
ToppCellmetastatic_Brain-Myeloid_cells-Monocytes|metastatic_Brain / Location, Cell class and cell subclass

LILRA2 CES1 ZEB2 S100A9 SERPINA1 SAT1 CD14

1.23e-051951757dfc24ee09bdc20d8a38feb8a4cc5f6b54a032981
ToppCellwk_15-18-Hematologic-Myeloid-Promonocyte-like|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

LILRA2 ASRGL1 S100A9 MKI67 CRYBG1 IL17RA AURKB

1.23e-05195175737b4f635b71734c6e0bc808a739af4bbe6bb47f6
ToppCell343B-Myeloid-Monocyte-CD14+_Monocyte|343B / Donor, Lineage, Cell class and subclass (all cells)

LILRA2 NR4A1 ZEB2 S100A9 SAT1 CD14 PNPLA8

1.23e-051951757b5ee368c97113432fc8fe742654cd538558f327c
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

ZEB2 ST14 S100A9 SERPINA1 SAT1 CD14 FURIN

1.27e-051961757a44a648bf209ce037bfc7b3adfcb220aab60728c
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_prolif-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

LILRA2 ERCC6 S100A9 SERPINA1 SIGLEC7 SAT1 CD14

1.27e-0519617571c497deecced6edebbb7cea79353fbf56d41befc
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CES1 DNAJA4 CFAP70 DNAH9 PALLD HYDIN ALOX15

1.32e-05197175791637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CES1 DNAJA4 CFAP70 DNAH9 PALLD HYDIN ALOX15

1.32e-05197175722c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CES1 DNAJA4 CFAP70 DNAH9 PALLD HYDIN ALOX15

1.32e-0519717573bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

CES1 DNAJA4 CFAP70 DNAH9 PALLD HYDIN ALOX15

1.32e-05197175787db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCellCOVID-19_Severe-Classical_Monocyte|World / disease group, cell group and cell class

LILRA2 CES1 ITGA1 S100A9 SERPINA1 CD14 IL17RA

1.32e-051971757344801997b89bd81d8d5c3c872934de523233a8d
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

LILRA2 CES1 ZEB2 S100A9 SERPINA1 CD14 IL17RA

1.36e-051981757cf0fda1a24449cfd8ed56ffc7841d8accb187949
ToppCell(0)_Myeloid|World / immune cells in Peripheral Blood (logTPM normalization)

LILRA2 NR4A1 ZEB2 S100A9 SERPINA1 SAT1 CD14

1.36e-051981757aca971ee9d6801bea52288d86b44defa9e306969
ToppCellcellseq2-Immune-Immune_Myeloid-iMON-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

LILRA2 ZEB2 S100A9 SERPINA1 SIGLEC7 CD14 IL17RA

1.36e-051981757a6aa113f0af4d25c032f440c3134fe4d88ca5055
ToppCellNS-critical-d_07-13|critical / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

ARHGAP32 ST14 NFIA LMO7 CPLANE1 PALLD ALOX15

1.36e-051981757a6e11c87b31beffb6af190c64b4ef3ee1d9dab8d
ToppCellCOVID-19_Severe-Myeloid-Classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class

LILRA2 CES1 ZEB2 S100A9 SERPINA1 CD14 IL17RA

1.36e-051981757dfe92577c7d1e63315c7564d5d99362c6e7d4d46
ToppCellCaecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype

LILRA2 DTNA S100A9 SERPINA1 SIGLEC7 CD14 PALLD

1.36e-051981757e684c3934c163aef4d284b69435832d2c9614f2a
ToppCellCaecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass

LILRA2 DTNA S100A9 SERPINA1 SIGLEC7 CD14 PALLD

1.36e-051981757a92c0cacb775aca6bbb302bd9e22c081a112a44d
ToppCellsevere-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

ZEB2 S100A9 SERPINA1 SAT1 CD14 TM4SF4 IL17RA

1.36e-051981757d5e525d2f2226d06a3fb985ce3a33555ff4b2e7b
ToppCell(00)_Monocyte|World / immune cells in Peripheral Blood (logTPM normalization)

LILRA2 NR4A1 ZEB2 S100A9 SERPINA1 SAT1 CD14

1.36e-0519817572252e756a8a25d32c16a723e833c1390a772c2a4
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

LILRA2 NR4A1 ZEB2 S100A9 SERPINA1 SAT1 CD14

1.36e-051981757c00dbe61dc25602f19bd42a760646680002961ca
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

LILRA2 CES1 ZEB2 S100A9 SERPINA1 CD14 IL17RA

1.36e-0519817577e1f08dae11a7cc7949a5622d82c7e6660d06dea
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

LILRA2 CES1 ZEB2 S100A9 SERPINA1 CD14 IL17RA

1.36e-051981757525adc91fd8f2ad957b1879a5bf3950baa7d5ef8
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

LILRA2 CES1 ZEB2 S100A9 SERPINA1 CD14 IL17RA

1.36e-05198175770e62d815b2a0aa5327ff94d6f4d503176e007b9
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

LILRA2 CES1 ZEB2 S100A9 SERPINA1 CD14 IL17RA

1.36e-0519817570128d00e6c3f99a026329dd169c0ea5e0e24c59c
ToppCellcellseq2-Immune-Immune_Myeloid-iMON|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

LILRA2 ZEB2 S100A9 SERPINA1 SIGLEC7 CD14 IL17RA

1.36e-051981757a0ceed8689d42be6b9cde89d6c182d10b3fb14fc
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

LILRA2 CES1 ZEB2 S100A9 SERPINA1 CD14 IL17RA

1.36e-05198175751c220507bb05aa6338fec494b8ecf4902437708
ToppCell10x5'-blood-Myeloid_Monocytic|blood / Manually curated celltypes from each tissue

LILRA2 NR4A1 ZEB2 S100A9 SERPINA1 SAT1 CD14

1.36e-051981757c0985fff359c78d0fc1b6f31885aa168c9f5fdae
ToppCellCOVID-19_Severe-Classical_Monocyte|COVID-19_Severe / Disease condition and Cell class

CES1 ZBTB43 ZEB2 S100A9 SERPINA1 CD14 IL17RA

1.41e-051991757ea1e2ccde3930fab6d04a9bf130837455c742474
ToppCellTracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK1 ARHGAP32 MYO1D CLASP2 NFIA MKLN1 EXOC4

1.41e-05199175794b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell10x5'-blood-Myeloid_Monocytic-Classical_monocytes|blood / Manually curated celltypes from each tissue

LILRA2 NR4A1 ZEB2 S100A9 SERPINA1 SAT1 CD14

1.41e-051991757cd4528ae4a4d8ed1da20b268c556ab9b3f03c374
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type.

MICAL1 POLA1 CBR1 FANCD2 MAST4 NUP155 AURKB

1.45e-052001757d933978b55fefe52cad599b36f6b47a0c7f71f96
ToppCellCOVID_vent-Myeloid|COVID_vent / Disease condition, Lineage, Cell class and subclass

LILRA2 CES1 S100A9 SERPINA1 SAT1 CD14 IL17RA

1.45e-052001757621af09aae34226902c03edf556562f3ab35a7d8
ToppCellIIH-mono1-|IIH / Condition, Cell_class and T cell subcluster

EPS8 NR4A1 ZEB2 S100A9 SERPINA1 SAT1 CD14

1.45e-052001757555207143ecc89cdd55c30a513b31cf5dfd26dbc
ToppCellCOVID_vent-Myeloid-Monocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass

LILRA2 CES1 S100A9 SERPINA1 SAT1 CD14 IL17RA

1.45e-052001757b0a5bee87700ce38f26f95a6f491da7e27cade51
ToppCellsevere-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

LILRA2 ZBTB43 ZEB2 S100A9 SERPINA1 CD14 IL17RA

1.45e-052001757f46689940fdea500ce2457eec412dd2c46705819
ToppCellIIH-mono1|IIH / Condition, Cell_class and T cell subcluster

EPS8 NR4A1 ZEB2 S100A9 SERPINA1 SAT1 CD14

1.45e-05200175785c090fa714a6a02703ed38d3d49788ec0119666
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DTNA ITGA1 ZEB2 PCDH15 ROBO1 PDE5A PALLD

1.45e-05200175734f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCellLPS_only-Endothelial-Endothelial-Artery|LPS_only / Treatment groups by lineage, cell group, cell type

EPS8 CTTNBP2 ITGA6 NR4A1 MAST4 DAAM1 PALLD

1.45e-052001757b17eb1587ca86c3d40515128a00a8d8fd787fccf
ToppCell10x3'2.3-week_14-16-Myeloid_monocytic-monocyte-CD14_monocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5'

LILRA2 CES1 S100A9 SERPINA1 SAT1 CD14 IL17RA

1.45e-052001757527b7388700096686293f3f6b112269e87908dfa
ToppCellCOVID-19-COVID-19_Severe-Myeloid-CD14+_Monocyte|COVID-19_Severe / Disease, condition lineage and cell class

LILRA2 CES1 ZEB2 S100A9 SERPINA1 CD14 IL17RA

1.45e-0520017576abee30708572519045e9456dac2017b5308817a
ToppCellCOVID_vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass

LILRA2 CES1 S100A9 SERPINA1 SAT1 CD14 IL17RA

1.45e-052001757e57452b73abb21cb3f645d45523ab93f6bef0243
ToppCellFetal_brain-organoid_Tanaka_cellReport-GW13-Stem_cells-Neuroepithelial_cell|GW13 / Sample Type, Dataset, Time_group, and Cell type.

MICAL1 POLA1 CBR1 FANCD2 MAST4 NUP155 AURKB

1.45e-0520017573d932765c31aef1f80a118d51e8e66c50a758dbb
ToppCellmoderate-Lymphoid-NKT-proliferating|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

ASRGL1 S100A9 SAT1 MKI67 PALLD ALOX15 AURKB

1.45e-052001757693adc310953b669c9b93e2e7a3346606f75c810
ToppCellLPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

AKAP6 ITGA1 ZEB2 FAT1 PDE5A CPLANE1 PALLD

1.45e-052001757dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCellprimary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

OBSCN CMYA5 FANCD2 NFIA SCG3 IL17RA

4.40e-05162175658da6bc04cdac0002b0e6a751c96ff95e1a7f70f
ToppCelldroplet-Liver-nan-3m-Lymphocytic-NK_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ERCC6 POLM CMYA5 TCEANC SEPTIN6 DNAJA4

4.71e-051641756950f87d9dacee45c9004a9bf894543de38f72ee5
ToppCelldroplet-Liver-nan-3m-Lymphocytic-NK/T|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ERCC6 POLM CMYA5 TCEANC SEPTIN6 DNAJA4

4.71e-051641756c33910a6d87580902e9e7bd27afe6ea63b5eff8d
ToppCelldroplet-Liver-nan-3m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ERCC6 POLM CMYA5 TCEANC SEPTIN6 DNAJA4

4.71e-051641756bf0d3ad9016a0b8011a2385bb92f0a4f5edad1d6
DrugNomifensine maleate [32795-47-4]; Up 200; 11.2uM; PC3; HT_HG-U133A

IL11 SETX SAMD9 RYK KCNH6 DNAJA4 IGHMBP2 B3GNT2 IL17RA CPLANE1 DNAH9

3.25e-07196173115863_UP
DrugDropropizine (R,S) [17692-31-8]; Down 200; 17uM; MCF7; HT_HG-U133A

DOCK1 TNK1 BCL7A ATP8B2 B4GALT6 VPS13D MAST4 IGHMBP2 FURIN MPHOSPH9 HSD17B1

3.25e-07196173117429_DN
DrugRanitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A

ERCC6 DTNA ALPK1 GLB1L2 NR4A1 S100A9 NOD1 DNAJA4 ANGEL2 ALDH4A1

2.93e-06198173102251_DN
Drug1-(2'-deoxy-beta-D-ribofuranosyl)-3-nitropyrrole

POLA1 POLA2 SERPINA1

1.48e-0571733CID000133025
DrugAlprostadil [745-65-3]; Up 200; 11.2uM; PC3; HT_HG-U133A

IL11 CRYBG2 SRSF5 POLM NSD2 ITGA6 PHF7 B3GNT2 HSD17B1

1.49e-0518917394099_UP
DrugFenofibrate [49562-28-9]; Down 200; 11uM; MCF7; HT_HG-U133A

DOCK1 ATP7B NSD2 DTNA ALPK1 ATP8B2 PIK3CB IGHMBP2 FURIN

1.91e-0519517397432_DN
DrugClobetasol propionate [25122-46-7]; Down 200; 8.6uM; PC3; HT_HG-U133A

IL11 DTNA ITGA1 LMO7 DNAJA4 PIK3CB ASTN2 LSS PAX9

1.99e-0519617394497_DN
DrugPantothenic acid calcium salt monohydrate [63409-48-3]; Up 200; 8uM; HL60; HT_HG-U133A

PHF7 NR4A1 ST14 CD1A VPS13D SIGLEC7 DNAJA4 TGFBRAP1 LSS

1.99e-0519617391311_UP
DrugBetahistine mesylate [54856-23-4]; Down 200; 17.2uM; MCF7; HT_HG-U133A

TNK1 SETX DTNA ZBTB43 ALPK1 BCL7A CBR1 MOGS ASTN2

1.99e-0519617394956_DN
DrugLactobionic acid [96-82-2]; Down 200; 11.2uM; PC3; HT_HG-U133A

ATP7B POLM ATP8B2 SERPINA1 VPS13D LMO7 PIK3CB ALDH4A1 PAX9

1.99e-0519617396605_DN
DrugU-62066 [87151-85-7]; Down 200; 1uM; PC3; HT_HG-U133A

IL11 NSD2 POLA1 GON4L NOD1 B3GNT2 ASTN2 IL17RA CPLANE1

2.07e-0519717394553_DN
DrugTelenzepine dihydrochloride [147416-96-4]; Up 200; 9uM; PC3; HT_HG-U133A

MICAL1 NPR1 SAMD9 ZBTB43 EXOSC2 MAST4 ANGEL2 ASTN2 ALDH4A1

2.15e-0519817395096_UP
DrugMyricetin [529-44-2]; Down 200; 12.6uM; PC3; HT_HG-U133A

POLA1 PHF7 ITGA1 SEPTIN6 CABYR NOD1 PIK3CB KHK CPLANE1

2.15e-0519817394090_DN
Drug(R)-(+)-Atenolol [56715-13-0]; Down 200; 15uM; PC3; HT_HG-U133A

IL11 NSD2 ITGA1 SERPINA1 VPS13D LMO7 PIK3CB ASB7 IL17RA

2.15e-0519817394259_DN
DrugPyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A

MICAL1 NPR1 MYO1D DTNA CASR VPS13D MAST4 IGHMBP2 ALOX15

2.15e-0519817393482_UP
DrugNifedipine [21829-25-4]; Down 200; 11.6uM; PC3; HT_HG-U133A

MICAL1 ARHGAP32 CLASP2 ST14 SEPTIN6 IGHMBP2 B3GNT2 TMCC2 PDZD2

2.15e-0519817397303_DN
DrugMetampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A

MICAL1 ERCC6 NSD2 DTNA B4GALT6 SERPINA1 B3GNT2 LSS KHK

2.15e-0519817392286_DN
DrugAC1L1IZ2

NPR1 SETX MYO1D CLPX PGK2 ACTR1B ACTR1A KHK DNAH9 YME1L1 AURKB

2.22e-0530417311CID000004795
DrugHexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A

DOCK1 TNK1 DTNA ZBTB43 SERPINA1 VPS13D ROBO1 ALDH4A1 KHK

2.24e-0519917396244_DN
DrugPenicillamine

ATP7B NR4A1 S100A9 CD14 PDE5A C4A C4B

2.26e-051111737ctd:D010396
DrugSperact

NPR1 ATP7B PDE5A DNAH9

3.04e-05241734CID000123688
DrugPhosphorus

IL11 CES1 DTNA CASR NR4A1 CD14

3.33e-05801736ctd:D010758
DrugMonensin sodium salt [22373-78-0]; Up 200; 5.8uM; MCF7; HT_HG-U133A

SETX DTNA ITGA6 CBLB ANGEL2 LSS IL17RA ALOX15

4.48e-0516817383443_UP
DrugNSC 714187

LILRA2 DSG1 ITGA6 CD1A CD14 FURIN

4.70e-05851736CID005288693
DrugBrn 4268484

POLA1 POLA2

5.74e-0521732CID000124859
Drug2-(p-n-butylanilino)purine

POLA1 POLA2

5.74e-0521732CID000496196
Drugpoly 5-methylthiouridylic acid

POLA1 POLA2

5.74e-0521732CID000196324
DrugFIACTP

POLA1 POLA2

5.74e-0521732CID000157388
DrugFMACTP

POLA1 POLA2

5.74e-0521732CID000157387
DrugRS)-FPMPApp

POLA1 POLA2

5.74e-0521732CID000469033
Drugpisiferic acid

POLA1 POLA2

5.74e-0521732CID000162209
DrugCS-92-TP

POLA1 POLA2

5.74e-0521732CID000476778
Drug2-(p-n-Butylanilino)-6-chloropurine

POLA1 POLA2

5.74e-0521732CID005466207
DrugdTTPalphaS

POLA1 POLA2

5.74e-0521732CID000161258
Drug2-(p-n-butylanilino)adenine

POLA1 POLA2

5.74e-0521732CID000127307
DrugHBGTP

POLA1 POLA2

5.74e-0521732CID003010594
DrugZami 1327

POLA1 POLA2

5.74e-0521732CID000119519
DrugN-AcO-TFA-AF

POLA1 POLA2

5.74e-0521732CID000119334
Drug7-nitroindole

POLA1 POLA2

5.74e-0521732CID000023396
Drugpy-2

IL11 VPS18 PGK2 PTPN11

6.59e-05291734CID000205225
DrugPuromycin dihydrochloride [58-58-2]; Down 200; 7.4uM; PC3; HT_HG-U133A

POLM NSD2 ITGA6 EXOSC2 ATP8B2 RYK S100A9 MOGS

8.82e-0518517386711_DN
DrugPrimaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A

ARHGAP32 SETX NSD2 ZBTB43 CBLB PIK3CB ALDH4A1 PALLD

9.86e-0518817384845_DN
DrugFluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; MCF7; HT_HG-U133A

SAMD9 DTNA BCL7A EXOSC2 S100A9 TGFBRAP1 LPIN2 PALLD

1.06e-0419017384114_DN
DrugNorethindrone [68-22-4]; Up 200; 13.4uM; HL60; HT_HG-U133A

IL11 ZSWIM8 DTNA CD1A SIGLEC7 LSS ALDH4A1 PALLD

1.14e-0419217382383_UP
Drug2,3-dichlorophenoxyacetic acid

DTNA POLA1 POLA2

1.17e-04131733CID000018105
DrugSelegiline hydrochloride [14611-52-0]; Down 200; 17.8uM; MCF7; HT_HG-U133A

DOCK1 DTNA ATP8B2 RYK B4GALT6 SERPINA1 TMCC2 MTHFD2L

1.18e-0419317384146_DN
DrugRapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A

ERCC6 POLM DTNA NR4A1 CBLB NOD1 SIGLEC7 DNAJA4

1.18e-0419317381183_UP
DrugTiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; HL60; HG-U133A

POT1 CLASP2 NR4A1 ZEB2 GTF2F2 SAT1 MKLN1 TNKS2

1.18e-0419317381412_DN
DrugFlucytosine [2022-85-7]; Down 200; 31uM; MCF7; HT_HG-U133A

TNK1 SETX POT1 ZBTB43 GLB1L2 BCL7A PIK3CB B3GNT2

1.18e-0419317385289_DN
Drugsemustine; Down 200; 100uM; PC3; HT_HG-U133A

CLSTN3 SEPTIN6 VPS13D NOD1 DNAJA4 ANGEL2 KHK MPHOSPH9

1.23e-0419417387492_DN
DrugTocainide hydrochloride; Up 200; 17.4uM; MCF7; HT_HG-U133A

ERCC6 MYO1D NSD2 CABYR LSS KHK IL17RA TNKS2

1.23e-0419417384838_UP
DrugAcetohexamide [968-81-0]; Down 200; 12.4uM; MCF7; HT_HG-U133A

MICAL1 ATP7B MAST4 DNAJA4 IGHMBP2 FURIN LPIN2 ALDH4A1

1.23e-0419417381707_DN
DrugBuPdGTP

POLM POLA1 POLA2 LSS

1.25e-04341734CID000123713
Drugprochlorperazine dimaleate salt; Up 200; 10uM; HL60; HT_HG-U133A

POLM DTNA CBLB PRDM10 NOD1 SIGLEC7 CD14 ALDH4A1

1.27e-0419517381156_UP
DrugSulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A

SAMD9 NDST2 ATP8B2 VPS13D MAST4 LPIN2 ALDH4A1 TNKS2

1.27e-0419517384740_DN
DrugICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A

MICAL1 ZBTB43 GON4L CBLB SERPINA1 VPS13D FURIN ALDH4A1

1.27e-0419517381630_UP
DrugRaloxifene hydrochloride [82640-04-8]; Up 200; 7.8uM; MCF7; HT_HG-U133A

SAMD9 ZBTB43 ATP8B2 CD1A VPS13D LPIN2 LSS ALDH4A1

1.27e-0419517386235_UP
DrugSpironolactone [52-01-7]; Up 200; 9.6uM; PC3; HT_HG-U133A

IL11 NSD2 VPS13D DNAJA4 IGHMBP2 MTHFD2L ALDH4A1 TNKS2

1.27e-0419517382064_UP
Drug6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A

IL11 ATP7B POLM DTNA BCL7A GTF2F2 MAST4 LPIN2

1.27e-041951738667_DN
DrugBiperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A

ZSWIM8 SAMD9 POLM NR4A1 ATP8B2 KHK PAX9 ALOX15

1.27e-0419517383321_UP
DrugOrnidazole [16773-42-5]; Down 200; 18.2uM; HL60; HG-U133A

LILRA2 GLB1L2 NR4A1 ST14 GTF2F2 SIGLEC7 BRPF1 MKI67

1.32e-0419617381425_DN
Drug6-Hydroxytropinone [5932-53-6]; Up 200; 25.8uM; MCF7; HT_HG-U133A

POLM ITGA6 CD1A SIGLEC7 IGHMBP2 ANGEL2 LPIN2 IL17RA

1.32e-0419617384833_UP
Drugestradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA

TNK1 NSD2 DTNA ST14 B4GALT6 NOD1 ASB7 IGHMBP2

1.32e-0419617381021_DN
DrugHomatropine hydrobromide (R,S) [51-56-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A

MICAL1 ZBTB43 BCL7A MAST4 FURIN ALDH4A1 IL17RA ALOX15

1.32e-0419617381684_DN
DrugDiphemanil methylsulfate [62-97-5]; Up 200; 10.2uM; PC3; HG-U133A

ASNSD1 POLM DTNA ALPK1 EXOSC2 VPS13D LPIN2 YME1L1

1.32e-0419617381912_UP
DrugCrotamiton [483-63-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A

DTNA TRIP10 B4GALT6 S100A9 VPS13D MOGS MTHFD2L LSS

1.36e-0419717385689_DN
DrugMemantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A

IL11 DTNA ZBTB43 ALPK1 B4GALT6 DNAJA4 MTHFD2L ALOX15

1.36e-0419717384135_DN
DrugGibberellic acid [77-06-5]; Up 200; 11.6uM; MCF7; HT_HG-U133A

POLM NSD2 DTNA POT1 NR4A1 LPIN2 LSS IL17RA

1.36e-0419717384818_UP
DrugTetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; PC3; HT_HG-U133A

SRSF5 PHF7 CASR GLB1L2 NR4A1 SERPINA1 MAST4 SIGLEC7

1.36e-0419717384078_UP
Drugrapamycin; Down 200; 0.1uM; MCF7; HG-U133A

IL11 ITGA6 VPS13D PTPN11 TGFBRAP1 KHK DNAH9 PALLD

1.36e-041971738326_DN
DrugNicergoline; Down 200; 8.2uM; HL60; HG-U133A

ARHGAP32 CLASP2 ALPK1 GLB1L2 SEPTIN6 MKI67 MPHOSPH9 TNKS2

1.36e-0419717381374_DN
DrugMesoridazine besylate [32672-69-8]; Down 200; 7.4uM; HL60; HG-U133A

LILRA2 SETX POT1 NDST2 CBR1 ZEB2 ACTR1A SERPINA1

1.36e-0419717381725_DN
DrugRapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A

IL11 LILRA2 ITGA1 KCNH6 CD1A PRDM10 MAST4 LSS

1.36e-0419717382667_UP
DrugKetorolac tromethamine [74103-07-4]; Up 200; 10.6uM; PC3; HT_HG-U133A

CRYBG2 SRSF5 DTNA B4GALT6 VPS13D NOD1 FURIN ASTN2

1.36e-0419717387286_UP
DrugScopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; HL60; HG-U133A

USP9X GTF2F2 VPS13D SIGLEC7 SAT1 LTN1 LPIN2 MKI67

1.41e-0419817381415_DN
DrugTetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A

ZSWIM8 POLM ALPK1 RYK MTHFD2L IL17RA TNKS2 ZNF574

1.41e-0419817382080_DN
Drug16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A

NSD2 DTNA VPS13D SIGLEC7 DNAJA4 ANGEL2 ALDH4A1 IL17RA

1.41e-0419817387505_DN
DrugNaringin hydrate [11032-30-7]; Down 200; 6.6uM; PC3; HT_HG-U133A

ATP7B NSD2 POLA2 B4GALT6 MOGS FURIN LPIN2 IL17RA

1.41e-0419817384605_DN
DrugSulfaguanidine [57-67-0]; Up 200; 18.6uM; MCF7; HT_HG-U133A

ZSWIM8 ITGA6 NR4A1 B4GALT6 SEPTIN6 TMCC2 TM4SF4 KHK

1.41e-0419817384839_UP
DrugEnalapril maleate [76095-16-4]; Down 200; 8.2uM; MCF7; HT_HG-U133A

TNK1 DTNA ATP8B2 SERPINA1 SAT1 TGFBRAP1 FURIN LSS

1.41e-0419817387428_DN
DrugIdazoxan hydrochloride [79944-56-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A

NPR1 DTNA ZBTB43 S100A9 CD1A SERPINA1 MAST4 LSS

1.41e-0419817385347_UP
DrugAlfaxalone [23930-19-0]; Down 200; 12uM; MCF7; HT_HG-U133A

ERCC6 ALPK1 GTF2F2 NOD1 MAST4 KHK IL17RA TNKS2

1.41e-0419817385451_DN
DrugOmeprazole [73590-58-6]; Down 200; 11.6uM; PC3; HT_HG-U133A

SETX POLA1 ZBTB43 SEPTIN6 SERPINA1 MKI67 ALDH4A1 KHK

1.41e-0419817386606_DN
DrugDioxybenzone [131-53-3]; Down 200; 16.4uM; MCF7; HT_HG-U133A

MICAL1 POT1 GON4L B4GALT6 S100A9 MTHFD2L LSS KHK

1.41e-0419817385699_DN
DrugRacecadotril [81110-73-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A

CRYBG2 SAMD9 ZBTB43 ITGA6 ATP8B2 ST14 VPS13D TMCC2

1.41e-0419817386231_UP
DrugCaffeic acid [3331-39-5]; Up 200; 22.2uM; MCF7; HT_HG-U133A

DTNA POT1 GON4L ALPK1 S100A9 NOD1 TGFBRAP1 LSS

1.41e-0419817385352_UP
DrugSulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; PC3; HT_HG-U133A

IL11 CRYBG2 DTNA GON4L EXOSC2 B4GALT6 FURIN LPIN2

1.46e-0419917386349_UP
Drug2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A

ARHGAP32 SAMD9 ALPK1 NR4A1 VPS13D NOD1 SIGLEC7 FURIN

1.46e-0419917386168_DN
DrugChlorambucil [305-03-3]; Down 200; 13.2uM; PC3; HT_HG-U133A

NSD2 POLA1 ZBTB43 CABYR SERPINA1 NOD1 MOGS ALDH4A1

1.46e-0419917384523_DN
DrugDizocilpine maleate [77086-22-7]; Up 200; 11.8uM; HL60; HG-U133A

AKAP6 IL11 ZSWIM8 ALPK1 SERPINA1 B3GNT2 LTN1 KHK

1.46e-0419917381386_UP
DrugVancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A

TNK1 ZSWIM8 GON4L MAST4 B3GNT2 LPIN2 ASTN2 ALOX15

1.46e-0419917382858_DN
DrugTrolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A

DOCK1 MICAL1 DTNA CBR1 ATP8B2 PTPN11 MAST4 SAT1

1.46e-0419917382883_DN
DrugIvermectin [70288-86-7]; Up 200; 4.6uM; PC3; HT_HG-U133A

IL11 SETX SAMD9 DTNA ITGA1 KCNH6 LMO7 DNAJA4

1.46e-0419917385853_UP
Drugclofibrate; Up 200; 100uM; MCF7; HG-U133A

ATP7B DTNA POLA1 POT1 CASR NOD1 TMCC2 KHK

1.46e-041991738444_UP
DrugAtracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A

MICAL1 ZBTB43 GON4L ATP8B2 TGFBRAP1 BRPF1 ASTN2 HSD17B1

1.46e-0419917381702_DN
DrugThioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; PC3; HT_HG-U133A

PHF7 POLA2 EXOSC2 CABYR NOD1 ASTN2 ALDH4A1 CPLANE1

1.46e-0419917384085_DN
DrugAmiloride hydrochloride dihydrate [17440-83-4]; Up 200; 13.2uM; MCF7; HT_HG-U133A

AKAP6 IL11 CRYBG2 ZBTB43 ALPK1 EXOSC2 ATP8B2 LSS

1.51e-0420017384109_UP
DrugMetformin hydrochloride [1115-70-4]; Up 200; 24.2uM; MCF7; HT_HG-U133A

CLASP2 KCNH6 NOD1 MAST4 TMCC2 LPIN2 ASTN2 LSS

1.51e-0420017385487_UP
DrugnPrdUTP

POLA1 POLA2

1.71e-0431732CID000122101
DrugO2-Et-dT

POLA1 POLA2

1.71e-0431732CID000124683
DiseaseLiver diseases

IL11 ATP7B SRSF5 SERPINA1 TM4SF4

6.30e-05721715C0023895
DiseaseLiver Dysfunction

IL11 ATP7B SRSF5 SERPINA1 TM4SF4

6.30e-05721715C0086565
DiseaseColorectal Carcinoma

AKAP6 VPS18 CLSTN3 ERCC6 ATP7B OBSCN ZEB2 CABYR FAT1 SIGLEC7 STRAP LMO7 MKI67 EXOC4

6.42e-0570217114C0009402
Diseaseresponse to anti-tuberculosis drug, drug-induced liver injury

ROBO1 ASTN2

9.98e-0531712EFO_0004228, EFO_0007918
Diseaseidiopathic osteonecrosis of the femoral head

SPRY3 CTTNBP2 SAMD9 ASTN2

2.37e-04521714EFO_1001930
DiseaseIntellectual Disability

AKAP6 NSD2 CAMK2A GON4L TSEN54 SHANK3 NFIA LSS ALDH4A1 TET3

2.97e-0444717110C3714756
Diseasereticulocyte measurement

MYO1D USP9X ITGA1 ZEB2 MRPL4 SERPINA1 FAT1 NOD1 SIGLEC7 DNAJA4 TMCC2 LTN1 LPIN2 PDE5A CFAP70 PDZD2

4.36e-04105317116EFO_0010700
DiseaseMajor Depressive Disorder

IL11 ATP7B CAMK2A NR4A1 CMYA5 SAT1 TPH1

5.62e-042431717C1269683
DiseaseMicrocephaly

ERCC6 NSD2 TSEN54 LSS

6.28e-04671714C0025958
Diseasegamma-glutamylmethionine measurement

NUDT12 ASTN2

6.88e-0471712EFO_0021141
Diseasecolorectal cancer (is_implicated_in)

ERCC6 CES1 POT1 FAT1 MKI67

7.13e-041211715DOID:9256 (is_implicated_in)
DiseaseTNF-related apoptosis-inducing ligand measurement

DSG1 DTNA B4GALT6 SERPINA1

8.24e-04721714EFO_0008300
Diseaseschizophrenia, intelligence, self reported educational attainment

AKAP6 SAMD9 SHANK3 ZEB2 TGFBRAP1 FURIN MPHOSPH9 EXOC4

9.69e-043461718EFO_0004337, EFO_0004784, MONDO_0005090
DiseaseAutoinflammatory disorder

POLA1 STING1 LPIN2

1.09e-03351713C3860213
Diseaseright ventricular systolic volume measurement

PTPN11 PDE5A PALLD

1.09e-03351713EFO_0021815
DiseaseGout

ALPK1 CD14

1.17e-0391712C0018099
Diseaseproteinuria (biomarker_via_orthology)

ZEB2 SERPINA1

1.46e-03101712DOID:576 (biomarker_via_orthology)
DiseaseAutism Spectrum Disorders

CTTNBP2 SHANK3 FEV TET3

1.53e-03851714C1510586
DiseaseKidney Neoplasm

ATP7B HLTF TPH1

1.61e-03401713C0022665
Diseaserenal cell carcinoma

POT1 ZEB2 PDZD2

1.86e-03421713EFO_0000681
Diseaseautism spectrum disorder (implicated_via_orthology)

ARHGAP32 CAMK2A NDST2 SHANK3 TPH1

1.97e-031521715DOID:0060041 (implicated_via_orthology)
DiseaseMalignant Head and Neck Neoplasm

FANCD2 FAT1 PIK3CB

2.13e-03441713C0278996
Diseasecolorectal cancer (is_marker_for)

ERCC6 CES1 POT1 SERPINA1 PIK3CB

2.26e-031571715DOID:9256 (is_marker_for)
DiseaseMalignant neoplasm of kidney

ATP7B HLTF TPH1

2.27e-03451713C0740457
Diseasethyroid peroxidase antibody measurement, anti-thyroglobulin antibody measurement

TRPM6 NUDT12 NFIA

2.27e-03451713EFO_0005666, EFO_0009896
DiseasePR interval

AKAP6 CRYBG2 DTNA OBSCN FAT1 NFIA LPIN2 MKLN1 ASTN2

2.49e-034951719EFO_0004462
Diseaseurinary bladder cancer (biomarker_via_orthology)

S100A9 MKI67

2.90e-03141712DOID:11054 (biomarker_via_orthology)
Diseaseglucose metabolism measurement, age-related hearing impairment

SAMD9 MYO1D GTF2F2

3.43e-03521713EFO_0005782, EFO_0009367
Diseaseinterleukin 1 receptor antagonist measurement

AKAP6 LILRA2 ASTN2

3.62e-03531713EFO_0004754
Diseaseidiopathic scoliosis (implicated_via_orthology)

PTPN11 PRMT5

3.80e-03161712DOID:0060250 (implicated_via_orthology)
DiseaseIntrahepatic cholestasis of pregnancy

SERPINA1 UBXN2B

3.80e-03161712EFO_0009048
Diseasephenylalanine measurement

VPS18 NUP37 PCDH15

4.02e-03551713EFO_0005001
DiseaseMalignant neoplasm of breast

AKAP6 MICAL1 ERCC6 ATP7B NSD2 OBSCN PHF7 ZEB2 PIK3CB DAW1 MKI67 ROBO1 ASTN2 DNAH9

4.05e-03107417114C0006142
DiseaseUnipolar Depression

IL11 ATP7B CAMK2A CMYA5 SAT1 TPH1

4.12e-032591716C0041696
DiseaseMuscle hypotonia

NSD2 LSS

4.29e-03171712C0026827
DiseaseCarcinoma, Granular Cell

SERPINA1 PTPN11 MKI67 ROBO1

4.71e-031161714C0205644
DiseaseAdenocarcinoma, Tubular

SERPINA1 PTPN11 MKI67 ROBO1

4.71e-031161714C0205645
DiseaseAdenocarcinoma, Oxyphilic

SERPINA1 PTPN11 MKI67 ROBO1

4.71e-031161714C0205642
DiseaseCarcinoma, Cribriform

SERPINA1 PTPN11 MKI67 ROBO1

4.71e-031161714C0205643
DiseaseAdenocarcinoma, Basal Cell

SERPINA1 PTPN11 MKI67 ROBO1

4.71e-031161714C0205641
DiseaseAdenocarcinoma

SERPINA1 PTPN11 MKI67 ROBO1

4.71e-031161714C0001418
Diseaseferritin measurement

EPS8 OTOP3 RYK NOD1

5.16e-031191714EFO_0004459
DiseaseCholecystitis

UBXN2B TM4SF4

5.35e-03191712HP_0001082

Protein segments in the cluster

PeptideGeneStartEntry
PKTVIGDHGDELFSV

CES1

461

P23141
EAKEPGLGVDFIRHN

ENKD1

191

Q9H0I2
FLEHGADPTVKDLIG

ASB7

66

Q9H672
PGHVFAVENGFKALR

ANTXRL

226

A6NF34
HGSGVPFEAVILDKA

CLSTN3

71

Q9BQT9
FLDEVDKIGSVPGIH

CLPX

356

O76031
HGLAVFQDEGAEPLK

C4B

1151

P0C0L5
AAAKDGKLHFGIDPD

ASRGL1

286

Q7L266
HLNEAGSLPAEKDAV

ATP7B

1126

P35670
FFLPDEGKLQHLENE

SERPINA1

276

P01009
GLFPIHFGVAAKDQD

CASR

36

P41180
GHGEFKLTDPDEVAR

FEV

71

Q99581
FLVIVDGSPKNDDGH

GZF1

606

Q9H116
ALEGDLFIGPKAEEH

ACTR1B

51

P42025
EHSRIKVGDPAEDFG

ALDH4A1

371

P30038
EGKPVLSGEAAEAVH

CABYR

446

O75952
QKILFHGEGDQEPEL

DNAJA4

221

Q8WW22
SGVFHVEGLDLSPKE

NPR1

736

P16066
EKEDVAGHPGAEVAL

ANGEL2

486

Q5VTE6
EGKDNVPEHFSGRAE

ERCC6

1361

Q03468
TLDSLGHPGEEKVDF

ASTN2

321

O75129
QPDDFEKLLAGVRHD

ALPK1

976

Q96QP1
VFDVLGHKAELGERP

ATP8B2

436

P98198
KIAVDGPPLHEFDFG

C17orf113

641

A0A1B0GUU1
VDFLITHPKEGQEAG

POLM

331

Q9NP87
DIKDQPENGHLGFQD

NFIA

201

Q12857
NLRFHVEEEGKGQDP

PGK2

121

P07205
TVGGFLENHEEPRDK

INTS6

766

Q9UL03
TFHGAGLVVPVDKND

HPF1

221

Q9NWY4
GFILCKEGEDEHPQR

LILRA2

151

Q8N149
FIDAVLKDPGLQHGQ

LTN1

441

O94822
VLPHFGKEDAGDVQQ

NR4A1

391

P22736
IEDGNEHGKFFIEPK

FAT1

1291

Q14517
IKDGNTGDAFDINPH

FAT1

1701

Q14517
AFGIHPEFENGLEKD

OTOP3

546

Q7RTS5
HQAILGPFGELLTED

ESPNL

491

Q6ZVH7
EEGGAAVAKLEPHLQ

IL17RA

641

Q96F46
AAPHAVNGLEKGALE

PAX9

236

P55771
SGLPDFVKELHDNGQ

MGAM2

386

Q2M2H8
DEAFRKEVVHIGPGI

LRIT2

401

A6NDA9
NLHEPERGKFDFSGN

GLB1L3

126

Q8NCI6
LGKNDIFGEPVSLHA

KCNH6

651

Q9H252
DLPLEGAKVFSNGHL

CBLB

646

Q13191
GNADGLKEPLSFHVT

CD1A

16

P06126
LAAQLRDKFPADGDH

IL11

56

P20809
VVDNPHSGLAGKLFA

KCNG2

166

Q9UJ96
NLKHGFQDATGSEPL

LRRC36

486

Q1X8D7
GHVFQLENGPDSLKE

PDZD2

261

O15018
GHVAALGEPLNIKDA

PDE5A

231

O76074
VFNGEPGAHDAKLRF

NSD2

86

O96028
DLPKAHTAFEGALNG

LSS

66

P48449
LEGHEGEISKISFNP

DAW1

341

Q8N136
PGEFEHNFLGENKVS

MPHOSPH9

116

Q99550
DEGAKAFAEALRNHP

NOD1

826

Q9Y239
VGEDPQGLFQKHREE

ALOX15

116

P16050
GLKEAQLFHPGDLQD

LMO7

136

Q8WWI1
LGKLEFAQDAHGQPD

MICAL1

346

Q8TDZ2
KSAHLLPEHIFDGEG

ITGA6

336

P23229
AIEDLAGFKDPAAGH

MKI67

2796

P46013
GEKSDDGTQDLLHFP

PRDM10

421

Q9NQV6
DPGGVLDFLEEVHHK

PTPN11

431

Q06124
VADHPGIDFGELSKK

HMGXB4

426

Q9UGU5
EGHTDFINGLVFDPK

NUP37

121

Q8NFH4
FNDIVIGAPLEDDHG

ITGA1

586

P56199
EGPAALQGKFHTIIE

ARHGAP32

626

A7KAX9
HKEEEAGGFIANLEP

EXOSC2

211

Q13868
AKDLLSDNVHFGPAG

DSG1

536

Q02413
YHKDEENDALLGGPA

POLA1

1251

P09884
EIAEKLGFKHFPEAG

NDUFA10

76

O95299
KHGEPEEDIVGLQAF

NUP155

951

O75694
APELGVFADFGNHTK

MOGS

646

Q13724
ALAPGKNVEIHAEGA

OBSCN

2026

Q5VST9
HFLQAPGDLTVQEGK

PALLD

1136

Q8WX93
FDLVIKAEQDNGHPL

PCDH15

361

Q96QU1
AVKHFGEEAGKIQPD

DAAM1

956

Q9Y4D1
KQAEEDAHLDGAVPI

ENOPH1

61

Q9UHY7
FIQEIEHALGLGPAK

EXOC4

506

Q96A65
EVEIHAGGLNLEPFL

CD14

56

P08571
DFHAEKLINAAPGGQ

HYDIN

4966

Q4G0P3
DEDGKRLEHVIFPGA

DOCK1

456

Q14185
IHQLFSKDLDIEPGG

B4GALT6

131

Q9UBX8
RQAEDGHFLEKGPVV

C3P1

231

Q6ZMU1
FFRPGAAGDHKLDEV

CPLANE1

1251

Q9H799
ELDQHTADFKGGSFP

CTTNBP2

1421

Q8WZ74
FNPEGGITSDDLAHK

CFAP70

66

Q5T0N1
ILDDGIEKNHPDLAG

FURIN

151

P09958
HREVFGDVPAKAEAG

HSD17B1

281

P14061
ADPGSLKQAFDDHNI

C3orf62

231

Q6ZUJ4
LSEEVSHPADFKKGG

CMYA5

1751

Q8N3K9
AEGVEPALGNEKEAH

CMYA5

2076

Q8N3K9
DFEGHGVEVSKALPD

CRYBG2

1271

Q8N1P7
ADGENAFQGLEPKLE

GON4L

1236

Q3T8J9
ALEGDIFIGPKAEEH

ACTR1A

51

P61163
DGAQHFLKDDGVSIP

PRMT5

451

O14744
AEGPHGQFVSEKRVE

CBR1

261

P16152
PAEGDKLEAGLSFVH

MAST4

2381

O15021
IGDHGKEARFPFLDE

ASNSD1

541

Q9NWL6
LAAFDPEGHGKISVF

DTNA

116

Q9Y4J8
NDFGILHETLPEEVG

HAUS6

771

Q7Z4H7
DALGPDGKLLHSDAF

KHK

231

P50053
LHEPERGKFDFSGNL

GLB1L2

101

Q8IW92
GSHLDQGEAAVAFKP

EPS8

501

Q12929
DAPGLEHAFKLLDIA

DNAH9

536

Q9NYC9
KDRPENVHGGILADD

HLTF

281

Q14527
NFEGHSIPLEEGELE

CRYBG1

1071

Q9Y4K1
KVDEAQADGKEHPGA

BCL7A

131

Q4VC05
KVLQQGHFEDDDPDG

SAMD1

521

Q6SPF0
ELAHKPGLVAGERAE

SCUBE3

606

Q8IX30
KEGHQEGLVELPASF

SCNN1D

206

P51172
FGRIFHGILIDEKDP

RYK

341

P34925
HGLAVFQDEGAEPLK

C4A

1151

P0C0L4
PEILGDSQHADVGKE

FANCD2

216

Q9BXW9
LTFHLLEFPEGKGVA

PNPLA8

386

Q9NP80
DLANIHDIGGKPASV

GTF2F2

61

P13984
KGQGSEESEDHFPLL

TSGA10IP

86

Q3SY00
HNALKGIPDDRDGLF

USP9X

2356

Q93008
FLDKLPQQTGDHAGI

STING1

221

Q86WV6
GHSVLPLEEAVEGFK

TRIM27

126

P14373
LGHPDTLNQGEFKEL

S100A9

26

P06702
GFEQERVGLADLHPD

MRPL4

71

Q9BYD3
GDVPLIFALVDHGDI

TSEN54

496

Q7Z6J9
FGSADNIAHLKDPLE

TMCC2

436

O75069
EDTAADGGPKLVFDH

MKLN1

376

Q9UL63
RGFHGFLPEDIKKEA

PHF7

76

Q9BWX1
GPGNLIDPIHEFKAF

SAMD9

186

Q5K651
VPHEGDLDIIFQDGA

POT1

391

Q9NUX5
VQKGDGFIHNLSLDP

SETX

831

Q7Z333
SFHKGEPQDLSGQEA

SIGLEC7

441

Q9Y286
LTEKDLLEDGFGEHP

SAT1

36

P21673
GIDPIAAEEFKQRHE

NUDT12

231

Q9BQG2
QHLIPKIEDGNDFGV

PSME2

126

Q9UL46
ILFGPFLDAKHEQVE

POLA2

376

Q14181
EPEALGNLVEGLDFH

CAMK2A

381

Q9UQM7
GKGLHEFDSLKDPEV

PIK3CB

131

P42338
GHVGFDSLPDQLVNK

SEPTIN6

21

Q14141
VHPKADGALKGEAEQ

SPRY3

121

O43610
FADAHRPKLNEGVVE

SRSF5

136

Q13243
LHPEKEFLVAGGEDF

STRAP

231

Q9Y3F4
HNKGDPNALVDEDAV

BRPF1

261

P55201
FIGDVIHNAGPHRDK

B3GNT2

271

Q9NY97
PDCLGEELQGKHDVF

AKAP6

1451

Q13023
LHKSGFARPGDVEFE

TRIP10

271

Q15642
VLGNKFDHGAEAIVP

CLASP2

166

O75122
HFTIDDFEIGRPLGK

AURKB

71

Q96GD4
GHTDFPKAQELRDGE

ZBTB43

161

O43298
EEGEDLHFPANEKKG

TNMD

201

Q9H2S6
GSELDADHPGFKDNV

TPH1

126

P17752
TLPFKEGHILQDFEG

TGFBRAP1

281

Q8WUH2
NELFKEAREHGAVPL

UBXN2B

86

Q14CS0
HRAPHDQEEGDVGLK

TRPM6

1121

Q9BX84
AIQLKPKEEHFGDGD

TCEANC

141

Q8N8B7
HPGLADFADNLIKES

TIAM2

1551

Q8IVF5
DENELEEQFVKGHGP

MTRFR

56

Q9H3J6
DTGPFFAGDADKLLH

STYXL1

196

Q9Y6J8
FIAVKAHSPQGEGEI

SHANK3

476

Q9BYB0
HPELEIKSVDGFQGR

IGHMBP2

556

P38935
EAAHAAAGPGEVLAK

ZNF574

686

Q6ZN55
GQVVLRDHFLEKFGP

VPS18

351

Q9P253
HEKVNGLEEGVEFLP

ST14

26

Q9Y5Y6
NKQFALEHGIPTDLG

NDST2

411

P52849
GVKSEPQFIQLDAHG

ROBO1

861

Q9Y6N7
FLDENIGGVAVAPAH

TET3

1646

O43151
PLHFAAGFGRKDVVE

TNKS2

61

Q9H2K2
GIAPEKDVDGFHIIN

MTHFD2L

161

Q9H903
PDGSHLAVDDLKNAE

TRPM1

1336

Q7Z4N2
PEAHQDAFKTGFAEG

YME1L1

261

Q96TA2
AGEEHDLFAGLKPLE

ZSWIM8

751

A7E2V4
EHFDFVKPEDLDGIG

TNK1

36

Q13470
EDKLHIAEDDGIANP

ZEB2

41

O60315
DDGVFHIGAAAQDKP

UHRF1BP1

1356

Q6BDS2
PGGKVIDDNDHLSQE

TM4SF4

31

P48230
GLDHKFQDDPDGLHQ

SCG3

126

Q8WXD2
PKDADNLFEHELGAL

ZC3H13

1556

Q5T200
RKEPAEFNGDGAFLH

ZNF649

126

Q9BS31
HLIGAPEKIQDFNDE

VPS13D

86

Q5THJ4
DHINLAVLADAEGKP

KIAA2013

491

Q8IYS2
QHQGPDDIYLDDLKG

LPIN2

396

Q92539
HLGNLKFVVDGDTPL

MYO1D

276

O94832